[Experimental atherogenesis in the Wistar rat].
D000284:Administration, Oral; D000818:Animals; D001012:Aorta, Abdominal / Q000473:pathology; D001013:Aorta, Thoracic / Q000473:pathology; D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology* / Q000401:mortality / Q000473:pathology; D002784:Cholesterol / Q000097:blood; D004036:Diet, Atherogenic; D004195:Disease Models, Animal; D004591:Electrophoresis, Polyacrylamide Gel; D004872:Ergocalciferols / Q000008:administration & dosage*; D005260:Female; D006025:Glycosaminoglycans / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D051381:Rats; D014280:Triglycerides / Q000097:blood
D004872:Ergocalciferols; D006025:Glycosaminoglycans; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D002784:Cholesterol
Athérogénèse expérimentale chez le rat Wistar